Who Supplies Imipenem? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Imipenem exports, with 140+ registered manufacturers shipping to buyers across 94+ countries — yet a handful of companies dominate the shipments. VENUS REMEDIES LIMITED holds the largest share at 15.5% (export value: $5.2M). Close behind, SUN PHARMACEUTICAL INDUSTRIES LIMITED (14.2%, $4.7M). SWISS PARENTERALS LIMITED (6.3%, $2.1M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Imipenem? Top Manufacturers & Their Buyers
Flow of Imipenem from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Imipenem Supplier Network — Key Market Intelligence
The Imipenem export market from India is led by VENUS REMEDIES LIMITED, which alone commands a 15.5% share, shipping $5.2M worth of product across 194 shipments. The second-largest exporter, SUN PHARMACEUTICAL INDUSTRIES LIMITED, contributes $4.7M (14.2%) to the overall market. Combined, the top two suppliers alone account for 29.7% of all Imipenem exports, indicating a relatively concentrated supply base.
Across all 140 tracked manufacturers, the total Imipenem export value stands at $33.3M from 803 shipments. The market average shipment value is $41.5K. The single largest buyer relationship in terms of trade value is YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN, receiving $1.9M worth of product.
The combined buyer network spans 17 named purchasing companies, including LABORATORIOS JAYOR S A DE C V, L J S.A DE CV, L J S A D C, ASCEND LABORATORIES SPA AVENIDA APOQUINDO, S T C and 12 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1VENUS REMEDIES LIMITED
VENUS REMEDIES LIMITED is the first-largest Imipenem exporter from India, with a market share of 15.5% and a total export value of $5.2M across 194 shipments. Their average shipment value of $26.6K is below the market average of $41.5K, reflecting a high-volume, competitive pricing strategy.
VENUS REMEDIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• LABORATORIOS JAYOR S A DE C V — $1.8M across 69 shipments (35.4% of this supplier's total exports)
• L J S.A DE CV — $1.1M across 41 shipments (21.0% of this supplier's total exports)
• L J S A D C — $944.6K across 35 shipments (18.3% of this supplier's total exports)
• ASCEND LABORATORIES SPA AVENIDA APOQUINDO — $719.0K across 27 shipments (13.9% of this supplier's total exports)
• S T C — $589.0K across 22 shipments (11.4% of this supplier's total exports)
Key Insight: VENUS REMEDIES LIMITED operates with high shipment frequency (194 shipments) at a per-shipment value of $26.6K, indicating a broad distribution network with many smaller, regular orders.
2SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the second-largest Imipenem exporter from India, with a market share of 14.2% and a total export value of $4.7M across 119 shipments. Their average shipment value of $39.8K is below the market average of $41.5K, reflecting a high-volume, competitive pricing strategy.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $1.9M across 47 shipments (39.2% of this supplier's total exports)
• M/S. SUN PHARMACEUTICALS MOROCCO LL — $1.4M across 35 shipments (29.8% of this supplier's total exports)
• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $565.8K across 14 shipments (11.9% of this supplier's total exports)
• M/S. HAPHARCO J.S.C BRANCH — $490.1K across 12 shipments (10.4% of this supplier's total exports)
• M/S. HAPHARCO J.S.C BRANCH — $412.1K across 10 shipments (8.7% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED operates with high shipment frequency (119 shipments) at a per-shipment value of $39.8K, indicating a broad distribution network with many smaller, regular orders.
3SWISS PARENTERALS LIMITED
SWISS PARENTERALS LIMITED is the third-largest Imipenem exporter from India, with a market share of 6.3% and a total export value of $2.1M across 9 shipments. Their average shipment value of $232.9K is above the market average of $41.5K, suggesting premium or bulk contract pricing.
SWISS PARENTERALS LIMITED serves 5 named buyers in our database. BANK OF CEYLON is the dominant customer, accounting for 55.9% of this supplier's tracked business. Top customers include:
• BANK OF CEYLON — $1.2M across 5 shipments (55.9% of this supplier's total exports)
• TO THE ORDER — $714.1K across 3 shipments (34.1% of this supplier's total exports)
• TO THE ORDER OF . — $80.4K across 0 shipments (3.8% of this supplier's total exports)
• TO THE ORDER OF . — $73.1K across 0 shipments (3.5% of this supplier's total exports)
• TO THE ORDER OF . — $56.3K across 0 shipments (2.7% of this supplier's total exports)
Key Insight: SWISS PARENTERALS LIMITED's per-shipment value of $232.9K is 461% above the market average of $41.5K, consistent with large-order contracts or value-added formulations.
4SUN PHARMACEUTICAL INDUSTRIES LTD
SUN PHARMACEUTICAL INDUSTRIES LTD is the fourth-largest Imipenem exporter from India, with a market share of 3.3% and a total export value of $1.1M across 15 shipments. Their average shipment value of $74.2K is above the market average of $41.5K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• M S RANBAXY PHARMACEUTICALS PTY LTD — $425.2K across 6 shipments (38.2% of this supplier's total exports)
• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $265.3K across 4 shipments (23.8% of this supplier's total exports)
• M/S. SUN PHARMACEUTICALS MOROCCO LL — $241.0K across 3 shipments (21.7% of this supplier's total exports)
• JDS CO LTD — $91.2K across 1 shipments (8.2% of this supplier's total exports)
• MS JDS CO LTD — $90.3K across 1 shipments (8.1% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LTD's per-shipment value of $74.2K is 79% above the market average of $41.5K, consistent with large-order contracts or value-added formulations.
5PROTECH BIO SYSTEMS PRIVATE LIMITED
PROTECH BIO SYSTEMS PRIVATE LIMITED is the fifth-largest Imipenem exporter from India, with a market share of 2.9% and a total export value of $959.8K across 19 shipments. Their average shipment value of $50.5K is above the market average of $41.5K, suggesting premium or bulk contract pricing.
PROTECH BIO SYSTEMS PRIVATE LIMITED serves 2 named buyers in our database. PHARMEDIC SA is the dominant customer, accounting for 97.4% of this supplier's tracked business. Top customers include:
• PHARMEDIC SA — $934.4K across 18 shipments (97.4% of this supplier's total exports)
• DONY TRIUMPH AND CO. — $25.4K across 1 shipments (2.6% of this supplier's total exports)
Key Insight: PROTECH BIO SYSTEMS PRIVATE LIMITED's per-shipment value of $50.5K is 22% above the market average of $41.5K, consistent with large-order contracts or value-added formulations.
6M J BIOPHARM PRIVATE LIMITED
M J BIOPHARM PRIVATE LIMITED is the fifth-largest Imipenem exporter from India, with a market share of 2.1% and a total export value of $713.1K across 9 shipments. Their average shipment value of $79.2K is above the market average of $41.5K, suggesting premium or bulk contract pricing.
M J BIOPHARM PRIVATE LIMITED serves 4 named buyers in our database. LIFELINE CO LIMITED is the dominant customer, accounting for 81.7% of this supplier's tracked business. Top customers include:
• LIFELINE CO LIMITED — $582.8K across 7 shipments (81.7% of this supplier's total exports)
• LIFELINE CO LTD — $82.1K across 1 shipments (11.5% of this supplier's total exports)
• S GENERIX PHARMA DIS — $30.7K across 0 shipments (4.3% of this supplier's total exports)
• S GENERIX PHARMA DIS — $17.5K across 0 shipments (2.5% of this supplier's total exports)
Key Insight: M J BIOPHARM PRIVATE LIMITED's per-shipment value of $79.2K is 91% above the market average of $41.5K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Imipenem Flows
Once Imipenem leaves the manufacturing plants of companies like VENUS REMEDIES LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED, it travels to 5 destination markets with a combined import value of $33.3M. Mexico absorbs the largest share at 27.2% ($9.1M), followed by Belgium (10.0%) and Sri Lanka (7.4%).
In Mexico — the top destination — named importers include LABORATORIOS JAYOR S.A. DE C.V., LABORATORIOS JAYOR S A DE C V, L J S.A DE CV. In Belgium, key buyers are YUSEN LOGISTICS BENELUX BELGIUM, YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN.
This geographic spread reflects Imipenem's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Imipenem Go? Top Importing Countries & Their Buyers
Trade flow of Imipenem exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Mexico
Mexico ranks as the first-largest destination for Imipenem imports from India, with a total trade value of $9.1M across 20 shipments — representing a 27.2% share of all Imipenem exports. The average shipment value of $453.4K is above the global average of $41.5K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.
Named Imipenem importers in Mexico: LABORATORIOS JAYOR S.A. DE C.V. is the largest buyer, accounting for 39.6% ($3.6M) of this market's total imports.
• LABORATORIOS JAYOR S.A. DE C.V. — $3.6M (39.6% of Mexico's total)
• LABORATORIOS JAYOR S A DE C V — $1.8M (20.2% of Mexico's total)
• L J S.A DE CV — $1.1M (12.0% of Mexico's total)
Key Insight: Mexico's per-shipment average of $453.4K (992% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Mexico is a key market for Imipenem imports from India.
2Belgium
Belgium ranks as the second-largest destination for Imipenem imports from India, with a total trade value of $3.3M across 38 shipments — representing a 10.0% share of all Imipenem exports. The average shipment value of $88.0K is above the global average of $41.5K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Imipenem importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 66.0% ($2.2M) of this market's total imports.
• YUSEN LOGISTICS BENELUX BELGIUM — $2.2M (66.0% of Belgium's total)
• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $831.1K (24.8% of Belgium's total)
Key Insight: Belgium's per-shipment average of $88.0K (112% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Belgium is a key market for Imipenem imports from India.
3Sri Lanka
Sri Lanka ranks as the third-largest destination for Imipenem imports from India, with a total trade value of $2.5M across 2 shipments — representing a 7.4% share of all Imipenem exports. The average shipment value of $1.2M is above the global average of $41.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Imipenem importers in Sri Lanka: BANK OF CEYLON is the largest buyer, accounting for 47.4% ($1.2M) of this market's total imports.
• BANK OF CEYLON — $1.2M (47.4% of Sri Lanka's total)
Key Insight: Sri Lanka's per-shipment average of $1.2M (2878% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Sri Lanka is a key market for Imipenem imports from India.
4Morocco
Morocco ranks as the fourth-largest destination for Imipenem imports from India, with a total trade value of $2.5M across 17 shipments — representing a 7.4% share of all Imipenem exports. The average shipment value of $144.6K is above the global average of $41.5K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Imipenem importers in Morocco: M/S. SUN PHARMACEUTICALS MOROCCO LL is the largest buyer, accounting for 57.3% ($1.4M) of this market's total imports.
• M/S. SUN PHARMACEUTICALS MOROCCO LL — $1.4M (57.3% of Morocco's total)
• MS SUN PHARMACEUTICALS MOROCCO LL — $548.3K (22.3% of Morocco's total)
Key Insight: Morocco's per-shipment average of $144.6K (248% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Morocco is a key market for Imipenem imports from India.
5Myanmar
Myanmar ranks as the fifth-largest destination for Imipenem imports from India, with a total trade value of $2.0M across 4 shipments — representing a 6.0% share of all Imipenem exports. The average shipment value of $502.6K is above the global average of $41.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Imipenem importers in Myanmar: LIFELINE CO LIMITED is the largest buyer, accounting for 29.0% ($582.8K) of this market's total imports.
• LIFELINE CO LIMITED — $582.8K (29.0% of Myanmar's total)
Key Insight: Myanmar's per-shipment average of $502.6K (1110% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Myanmar is a key market for Imipenem imports from India.
People Also Ask — Imipenem Supplier & Trade Network
Who are the top suppliers of Imipenem from India?+
Which companies buy Imipenem from Indian manufacturers?+
Where does Imipenem exported from India go?+
What is the market share of the top Imipenem supplier from India?+
What is the average shipment value for Imipenem exports from India?+
Is Imipenem manufactured in India and exported globally?+
Which country imports the most Imipenem from India?+
Who are the buyers of Imipenem in Belgium?+
How concentrated is the Imipenem supplier market in India?+
How do I find verified buyers for Imipenem in specific countries?+
Imipenem Trade Network — Key Takeaways
- 1VENUS REMEDIES LIMITED is India's dominant Imipenem exporter with a 15.5% market share and $5.2M in total exports — making it the single most important sourcing entity in this market.
- 2The top 140 suppliers collectively account for 44.3% of all tracked Imipenem exports, with a combined trade value of $33.3M.
- 3Mexico is the largest destination market, absorbing 27.2% of India's Imipenem exports ($9.1M). Belgium (10.0%) and Sri Lanka (7.4%) follow.
- 4With 803 total shipments averaging $41.5K each, the Imipenem export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include LABORATORIOS JAYOR S A DE C V, L J S.A DE CV, YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN, M/S. SUN PHARMACEUTICALS MOROCCO LL — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 94 countries
Network value: $33.3M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Imipenem — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Imipenem.
- 2.Flow Mapping: 140 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 803 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 94 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
803 Verified Shipments
140 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists